Boris Shor

Biochemical, Cellular, and <i>In vivo</i> Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin

Ker Yu, Lourdes Toral‐Barza, Celine Shi et al. · Cancer Research · 2009 · 326 citations

Chemoprevention Strategy, Cellular Pharmacology, Selective Inhibitors +22

Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2

Ker Yu, Celine Shi, Lourdes Toral‐Barza et al. · Cancer Research · 2010 · 208 citations · Full text

Antitumor Activity, Chemoprevention Strategy, Pharmacotherapy +22

Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells

Boris Shor, Jiang Wu, Quazi Shakey et al. · Journal of Biological Chemistry · 2010 · 183 citations · Full text

Tumor Biology, Transcriptional Regulation, Signaling Pathway +13

A New Pharmacologic Action of CCI-779 Involves FKBP12-Independent Inhibition of mTOR Kinase Activity and Profound Repression of Global Protein Synthesis

Boris Shor, Weiguo Zhang, Lourdes Toral‐Barza et al. · Cancer Research · 2008 · 120 citations · Full text

Chemoprevention Strategy, Global Protein Synthesis, Cancer Biology +20

Cpc2/RACK1 Is a Ribosome-associated Protein That Promotes Efficient Translation in Schizosaccharomyces pombe

Boris Shor, Jimmy Calaycay, Julie Ivory Rushbrook et al. · Journal of Biological Chemistry · 2003 · 86 citations · Full text

Ribosome-associated Protein, Molecular Regulation, Molecular Biology +18